Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights

Griffiths, 2000, Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism, Hum Mol Genet, 9, 2377, 10.1093/hmg/9.16.2377 Harris, 1995, Aceruloplasminemia: molecular characterization of this disorder of iron metabolism, Proc Natl Acad Sci USA, 92, 2539, 10.1073/pnas.92.7.2539 Yoshida, 1995, A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans, Nat Genet, 9, 267, 10.1038/ng0395-267 Miyajima, 1987, Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration, Neurology, 37, 761, 10.1212/WNL.37.5.761 Logan, 1994, Hereditary caeruloplasmin deficiency, dementia and diabetes mellitus, Q J Med, 87, 663 Morita, 1995, Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family, Ann Neurol, 37, 646, 10.1002/ana.410370515 Mukhopadhyay, 1998, Role of ceruloplasmin in cellular iron uptake, Science, 279, 714, 10.1126/science.279.5351.714 Kaplan, 1996, Iron metabolism in eukaryotes: Mars and Venus at it again, Science, 271, 1510, 10.1126/science.271.5255.1510 Harris, 1999, Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux, Proc Natl Acad Sci USA, 96, 10812, 10.1073/pnas.96.19.10812 Osaki, 1996, The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum, J Biol Chem, 241, 2746, 10.1016/S0021-9258(18)96527-0 Gosriwatana, 1999, Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin, Anal Biochem, 273, 212, 10.1006/abio.1999.4216 Erel, 1998, Automated measurement of serum ferroxidase activity, Clin Chem, 44, 2313, 10.1093/clinchem/44.11.2313 Cavill, 1977, Plasma clearance studies, 214 Stuart, 1977, Radionucleide blood cell survival studies, 245 Gandon, 1994, Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging, Radiology, 193, 533, 10.1148/radiology.193.2.7972774 Koschinsky, 1986, Complete cDNA sequence of human preceruloplasmin, Proc Natl Acad Sci USA, 83, 5086, 10.1073/pnas.83.14.5086 Brissot, 1981, Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods, Gastroenterology, 80, 557, 10.1016/0016-5085(81)90019-6 Brissot, 1978, Ascorbic acid status in idiopathic hemochromatosis, Digestion, 17, 479, 10.1159/000198154 Frieden, 1981, Ceruloplasmin: a multifunctional metalloprotein of vertebrate plasma, 117 Daimon, 1995, A nonsense mutation of the ceruloplasmin gene in hereditary ceruloplasmin deficiency with diabetes mellitus, Biochem Biophys Res Commun, 217, 89, 10.1006/bbrc.1995.2749 Miyajima, 1999, Estimation of the gene frequency of aceruloplasminemia in Japan, Neurology, 53, 617, 10.1212/WNL.53.3.617 Klomp, 1996, Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia, Hum Mol Genet, 5, 1989, 10.1093/hmg/5.12.1989 Patel, 1997, A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes, J Biol Chem, 272, 20185, 10.1074/jbc.272.32.20185 Patel, 2000, Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain, J Biol Chem, 275, 4305, 10.1074/jbc.275.6.4305 Brissot, 1997, Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats, Hepatology, 25, 1457, 10.1002/hep.510250625 Levy, 2000, Genes that modify the hemochromatosis phenotype in mice, J Clin Invest, 105, 1209, 10.1172/JCI9635 Miyajima, 1998, Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia, Neurology, 50, 130, 10.1212/WNL.50.1.130 Miyajima, 1996, Increased plasma lipid peroxidation in patients with aceruloplasminemia, Free Radic Biol Med, 20, 757, 10.1016/0891-5849(95)02178-7 Deugnier, 1992, Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations, Gastroenterology, 102, 2050, 10.1016/0016-5085(92)90331-R Deugnier, 1993, Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients, Hepatology, 18, 1363 Moirand, 1997, A new syndrome of liver iron overload with normal transferrin saturation, Lancet, 349, 95, 10.1016/S0140-6736(96)06034-5 Turlin, 2001, Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients, Am J Clin Pathol, 116, 263, 10.1309/WWNE-KW2C-4KTW-PTJ5 Niederau, 1996, Long term survival in patients with hereditary hemochromatosis, Gastroenterology, 110, 1107, 10.1053/gast.1996.v110.pm8613000 Daimon, 1995, Biochem Biophys Res Commun, 217, 89, 10.1006/bbrc.1995.2749 Kahn, 2001, Obesity, body fat distribution, insulin sensitivity and islet b-cell function as explanations for metabolic diversity, J Nutr, 131, 354S, 10.1093/jn/131.2.354S Miyajima, 1997, Use of desferrioxamine in the treatment of aceruloplasminemia, Ann Neurol, 41, 404, 10.1002/ana.410410318 Habgood, 1999, Investigation into the correlation between the structure of hydroxypyridinones and blood–brain barrier permeability, Biochem Pharmacol, 57, 1305, 10.1016/S0006-2952(99)00031-3